Non-F-18-FDG PET/CT in the management of patients affected by HNC: state-of-the-art

作者：Quartuccio Natale; Caobelli Federico; Di Mauro Francesca; Cammaroto Giovanni

来源：Nuclear Medicine Communications, 2016, 37(9): 891-898.

DOI：10.1097/MNM.0000000000000530

• fluorohymidine
• head and neck cancer
• hypoxia imaging
• methionine
• non-F-18-FDG PET
• CT
• PET
• somatostatin receptor imaging

PET/computed tomography with F-18-fluorodeoxyglucose is considered a powerful molecular imaging technique that can provide useful information in the management of patients affected by head and neck cancer. However, misleading findings have been reported because of nonspecific uptake caused by peritumoural inflammation and physiologic changes in nonmalignant tissues in the head and neck region. More specific -emitting tracers have been introduced that can track other pathological processes. We aimed to review the existing literature performing the search until June 2015 on non-F-18-fluorodeoxyglucose PET tracers in head and neck cancer to highlight their role in clinical practice.

• 出版日期2016-9